» Articles » PMID: 31482503

Clinical Applications of Hyaluronidase

Overview
Date 2019 Sep 5
PMID 31482503
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Hyaluronidases are enzymes that degrade hyaluronic acid, which constitutes an essential part of the extracellular matrix. Initially discovered in bacteria, hyaluronidases are known to be widely distributed in nature and have been found in many classes including insects, snakes, fish and mammals. In the human, six different hyaluronidases, HYAL1-4, HYAL-P1 and PH-20, have been identified. PH-20 exerts the strongest biologic activity, is found in high concentrations in the testicles and can be localized on the head and the acrosome of human spermatozoa. Today, animal-derived bovine or ovine testicular hyaluronidases as well as synthetic hyaluronidases are clinically applied as adjuncts to increase the bioavailability of drugs, for the therapy of extravasations, or for the management of complications associated with the aesthetic injection of hyaluronic acid-based fillers. Further applications in the fields of surgery, aesthetic medicine, immunology, oncology, and many others can be expected for years to come. Here, we give an overview over the molecular and cellular mode of action of hyaluronidase and the hyaluronic acid metabolism, as well as over current and potential future clinical applications of hyaluronidase.

Citing Articles

Hyaluronic acid-targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals.

Xue G, Tang L, Pan X, Li S, Zhao J Front Oncol. 2024; 14:1520274.

PMID: 39737406 PMC: 11682985. DOI: 10.3389/fonc.2024.1520274.


Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo.

Wang Z, Liu Y, Xu Y, Lu L, Zhu Z, Lv B MAbs. 2024; 16(1):2412881.

PMID: 39381966 PMC: 11469434. DOI: 10.1080/19420862.2024.2412881.


Biochemical Characterization of Hyaluronate Lyase CpHly8 from an Intestinal Microorganism Clostridium perfringens G1121.

Fu Y, Fu Z, Yu J, Wang H, Zhang Y, Liu M Appl Biochem Biotechnol. 2024; 197(2):771-792.

PMID: 39235659 DOI: 10.1007/s12010-024-05025-y.


Substitution of acidic residues near the catalytic Glu131 leads to human HYAL1 activity at neutral pH via charge-charge interactions.

Nguyen T, Hoang T, Nguyen T, Jeong C, Tran T, Choi M PLoS One. 2024; 19(8):e0308370.

PMID: 39121049 PMC: 11315327. DOI: 10.1371/journal.pone.0308370.


Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations.

Kroumpouzos G, Treacy P JMIR Dermatol. 2024; 7:e50403.

PMID: 38231537 PMC: 10836581. DOI: 10.2196/50403.


References
1.
Ahmed S, Ahmed O . Hyaluronidase revisited-a single injection technique for harvesting split thickness skin grafts under local anaesthesia. Br J Plast Surg. 2004; 57(6):589-91. DOI: 10.1016/j.bjps.2003.12.006. View

2.
Albanell J, Baselga J . Systemic therapy emergencies. Semin Oncol. 2000; 27(3):347-61. View

3.
Alberts D, Dorr R . Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum. 1991; 18(4):693-5. View

4.
Allen C, Etzwiler L, Miller M, Maher G, Mace S, Hostetler M . Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration. Pediatrics. 2009; 124(5):e858-67. DOI: 10.1542/peds.2008-3588. View

5.
Aruffo A, Stamenkovic I, Melnick M, Underhill C, Seed B . CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990; 61(7):1303-13. DOI: 10.1016/0092-8674(90)90694-a. View